Thalidomide: A Crucial Confrontation

This chapter delves into Dr. Kelsey's early experiences at the FDA, focusing on her pivotal role in the evaluation of the controversial drug thalidomide. Amid initial enthusiasm for the drug, her thorough investigation unveiled serious safety concerns, ultimately protecting public health from a potentially disastrous approval.